House committee advances Medicare coverage bill for breakthrough devices

AdvaMed welcomed the committee’s work on the legislation but called for the inclusion of diagnostics in the bill.

By Nick Paul Taylor • Sept. 18, 2025

FTC warns healthcare companies about restrictive noncompete contracts

Chair Andrew Ferguson has sent letters to large healthcare employers and staffing firms asking them to review their employment contracts as the FTC pursues targeted enforcement of illegal noncompetes.

By Rebecca Pifer • Sept. 12, 2025

Supreme Court to hear Trump’s tariff legality case in November

The high court granted an expedited review of an appellate court finding that the president's sweeping tariffs were illegal.

By Antone Gonsalves • Sept. 10, 2025

Philips under investigation by Paris Prosecutor’s Office over recalled respiratory devices

The prosecutor’s office opened an investigation in June, with charges including aggravated fraud and failure to report incidents that pose serious health risks.

By Elise Reuter • Sept. 10, 2025

Judge allows Epic antitrust suit to move forward

A judge dismissed several claims brought by startup Particle Health against the EHR giant, but allowed some federal allegations to continue in court. 

By Emily Olsen • Sept. 9, 2025

Appellate court rules Trump’s global tariffs illegal, but delays action

The court intends to strike down the tariffs by mid-October, pending a Supreme Court review of the ruling.

By Antone Gonsalves • Sept. 2, 2025

Apple updates smart watches with blood oxygen feature after customs ruling

Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.

By Elise Reuter • Aug. 14, 2025

FTC moves to block Edwards’ JenaValve acquisition

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

By Susan Kelly • Aug. 6, 2025

Quest, Labcorp downplay ‘Big Beautiful Bill’ impact

Executives at the laboratory companies said they expect the effects on testing services from the Republicans’ tax and domestic policy bill, including cuts to Medicaid, will be minimal.

By Susan Kelly • July 29, 2025

EU, Canada delay retaliatory tariffs against US

Meanwhile, Brazil announced its own countermeasures while Mexico remains confident it will reach a deal by Aug. 1.

By Philip Neuffer • July 15, 2025

Court orders HHS to restore webpages related to ‘gender ideology’

A federal judge ordered the government to reinstate critical documents as soon as possible, but left the door open for the Trump administration to take a second crack at removing the data.

By Susanna Vogel • July 8, 2025

Carmat files for insolvency amid cash crunch

The artificial heart maker ran a crowdfunding campaign to try to raise some of the 3.5 million euros it needed to fund operations into July.

By Nick Paul Taylor • July 1, 2025

Supreme Court upholds ACA preventive services mandate

The high court preserved a key portion of the Affordable Care Act that requires private insurers to cover a range of preventive healthcare services without cost sharing.

By Emily Olsen • June 27, 2025

Could the FDA take an indirect approach to regulate LDTs?

Attorneys said many questions remain about LDT regulation after the FDA lost its legal fight. A recent warning letter could be a clue to future enforcement.

By Susan Kelly • June 16, 2025

Vaccine makers face fresh uncertainty after firing of CDC panel

The abrupt termination of the 17 panelists guiding the CDC’s vaccine recommendations could yield a new committee more aligned with Robert F. Kennedy Jr.’s skeptical views, analysts warned.

By Delilah Alvarado • June 10, 2025

Owens & Minor spikes $1.36B Rotech buyout over regulatory barriers

The companies scrapped the merger because securing FTC clearance “proved unviable in terms of time, expense and opportunity.”

By Nick Paul Taylor • June 6, 2025

FDA declines to appeal court order that stopped LDT final rule

“The Trump Administration has effectively ended the Biden Administration's attempt to regulate lab-developed tests,” TD Cowen analysts wrote.

By Susan Kelly • June 3, 2025

US court blocks Trump’s sweeping tariffs

The Court of International Trade said the president overstepped his authority, halting various duties. After an appeal, the ruling has been paused.

By Edwin Lopez • Updated May 29, 2025

J&J subsidiary ordered to pay $147M for violating antitrust rules

A jury found that Biosense Webster withheld services to hospitals using reprocessed catheters.

By Elise Reuter • May 20, 2025

Regeneron wins bid to buy 23andMe out of bankruptcy

The biotech, which has for years invested in genetics research, plans to acquire "substantially all" of testing firm 23andMe's assets for $256 million.

By Ned Pagliarulo • May 19, 2025

Trump policies are upending healthcare. Track the effect on the medtech industry here.

The FDA has rolled out an AI tool agency-wide, while a proposed HHS budget shows large cuts for the National Institutes of Health.

By MedTech Dive Staff • Updated June 6, 2025

HHS sued again over cuts to public health grants

In another lawsuit against the HHS over the grant cuts, municipalities in Texas, Tennessee, Ohio and Missouri, as well as a labor union, argue eliminating the funding would weaken their ability to respond to infectious disease outbreaks.

By Emily Olsen • May 1, 2025

Senators call for investigation into BCI privacy

In a letter to the FTC, three Democratic senators called for privacy standards for brain computer interface technology.

By Elise Reuter • Updated April 30, 2025

HHS layoffs may be illegal, legal experts say

The federal health department sidestepped normal procedures as it laid off 10,000 employees, according to sources. One union has already filed an internal complaint, while at least two law firms are exploring suits.

By Rebecca Pifer • April 21, 2025

Illinois, Minnesota join FTC challenge against $627M Surmodics buyout

The Illinois attorney general said the deal represents a “troubling trend of wealthy investors attempting to limit competition and innovation.”

By Nick Paul Taylor • April 18, 2025